Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.007 par value
-
Shares outstanding
-
2.03M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
277K
-
Shares change
-
+277K
-
Total reported value, excl. options
-
$819K
-
Value change
-
+$819K
-
Number of buys
-
12
-
Price
-
$2.96
Significant Holders of bioAffinity Technologies, Inc. - Common Stock, $0.007 par value (BIAF) as of Q3 2025
12 filings reported holding BIAF - bioAffinity Technologies, Inc. - Common Stock, $0.007 par value as of Q3 2025.
bioAffinity Technologies, Inc. - Common Stock, $0.007 par value (BIAF) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 277K shares
of 2.03M outstanding shares and own 13.66% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (243K shares), Scientech Research LLC (16.6K shares), VANGUARD GROUP INC (10.4K shares), Tower Research Capital LLC (TRC) (2.5K shares), Allworth Financial LP (1.79K shares), BANK OF AMERICA CORP /DE/ (1.68K shares), IFP Advisors, Inc (833 shares), UBS Group AG (143 shares), CITIGROUP INC (75 shares), and Larson Financial Group LLC (33 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.